Spi-1005 Updates 2024. Seattle, washington — sound pharmaceuticals, a biopharmaceutical company, has announced the completion of enrollment in its phase 3. (spi) is pleased to announce that is has received a $1.1m supplement to its $3.1m national center for.
Sound pharmaceuticals will unveil promising phase 2b stop ototoxicity data at the aro midwinter meeting, showcasing. 06 apr, 2021, 09:15 et.
Seattle — Sound Pharmaceuticals Is Pleased To Announce That The Fda’s Division Of Neurology Products Has Granted Its Request For Fast Track Designation (Ftd).
(spi) is pleased to announce a cooperative grant award from the national center.
06 Apr, 2021, 09:15 Et.
Seattle, washington — sound pharmaceuticals, a biopharmaceutical company, has announced the completion of enrollment in its phase 3.
28 Jul, 2022, 09:15 Et.
Sound pharmaceuticals will unveil promising phase 2b stop ototoxicity data at the aro midwinter meeting, showcasing.
Images References :
(Spi) Is Pleased To Announce A Cooperative Grant Award From The National Center.
Seattle, washington — sound pharmaceuticals, a biopharmaceutical company, has announced the completion of enrollment in its phase 3.
Seattle — Sound Pharmaceuticals Is Pleased To Announce That The Fda’s Division Of Neurology Products Has Granted Its Request For Fast Track Designation (Ftd).
Sound pharmaceuticals is pleased to announce that the fda’s division of neurology products has granted its request for fast track designation (ftd) involving.
06 Apr, 2021, 09:15 Et.
Sound pharmaceuticals will unveil promising phase 2b stop ototoxicity data at the aro midwinter meeting, showcasing.